Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)
China flag China · Delayed Price · Currency is CNY
17.17
-0.81 (-4.51%)
May 28, 2026, 3:00 PM CST

SHA:605077 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,0191,159434.212,1281,0401,244
Short-Term Investments
-554.39583.66461.79387.5-
Trading Asset Securities
105.032000.030.180.2270.05
Cash & Short-Term Investments
1,1241,9131,0182,5901,4281,314
Cash Growth
38.80%87.95%-60.70%81.38%8.72%427.99%
Accounts Receivable
776.7694.07769.01500.31392.94242.55
Other Receivables
34.0415.2726.76.058.1414.58
Receivables
810.74709.34795.71506.37401.08257.13
Inventory
916.51768.73697.39282.04279.06199.74
Other Current Assets
627.1125.1764.2136.1629.8732.23
Total Current Assets
3,4783,4162,5753,4152,1381,803
Property, Plant & Equipment
3,7873,8013,5881,8441,355991.3
Long-Term Investments
77.1973.793.4994.42122.5358.56
Goodwill
346.16346.16346.16346.1626.1126.11
Other Intangible Assets
295.75297.78305.87282.65242.4690.06
Long-Term Deferred Tax Assets
38.3435.7823.538.133.957.37
Long-Term Deferred Charges
28.8333.0335.1317.2911.1412.54
Other Long-Term Assets
30.736.3324.89169.795.6215.4
Total Assets
8,0828,0406,9926,1783,9053,004
Accounts Payable
1,106645.28443.34208.42169.9228.07
Accrued Expenses
29.54157.46122.6488.5571.2441.37
Short-Term Debt
600.33704.11150.3247.12260.24119.82
Current Portion of Long-Term Debt
606.79306.82226.64171.6539.74-
Current Portion of Leases
-3.380.950.561.24-
Current Income Taxes Payable
34.8823.9337.132.34--
Current Unearned Revenue
28.5528.8215.0119.9512.058.58
Other Current Liabilities
103.25564.07677.18253.16215.1257.88
Total Current Liabilities
2,5092,4341,6731,022769.53455.72
Long-Term Debt
2,0522,1101,8591,868345.4620.02
Long-Term Leases
7.527.063.20.020.511.46
Long-Term Unearned Revenue
157.53160.08118.2894.2151.3738.4
Long-Term Deferred Tax Liabilities
71.874.1482.6292.1974.3753.95
Other Long-Term Liabilities
----8-
Total Liabilities
4,7984,7853,7373,0771,249569.56
Common Stock
303.05303.05305.88234.61228.46163.18
Additional Paid-In Capital
1,4291,4271,4411,4791,4051,470
Retained Earnings
1,3731,3511,3631,2571,023801.28
Treasury Stock
-36.1-36.1-61.99-77.37--
Comprehensive Income & Other
196.1196.07196.13196.23-0.01-0.02
Total Common Equity
3,2643,2403,2433,0892,6562,434
Minority Interest
19.2614.311.8911.59--
Shareholders' Equity
3,2843,2553,2553,1012,6562,434
Total Liabilities & Equity
8,0828,0406,9926,1783,9053,004
Total Debt
3,2673,1312,2412,288647.18141.3
Net Cash (Debt)
-2,143-1,218-1,223302.51780.961,172
Net Cash Growth
----61.26%-33.38%1135.67%
Net Cash Per Share
-6.97-4.01-3.231.022.634.08
Filing Date Shares Outstanding
316.73299.43299.43296.99296.99296.99
Total Common Shares Outstanding
316.73299.43299.43296.99296.99296.99
Working Capital
968.84982.54902.052,3931,3691,347
Book Value Per Share
10.3110.1710.189.748.948.20
Tangible Book Value
2,6232,5972,5912,4612,3872,318
Tangible Book Value Per Share
8.288.028.007.628.047.81
Buildings
-1,3791,014576.89429.74336.07
Machinery
-3,4182,2621,8031,429960.55
Construction In Progress
-284.291,330290.58110.27230.98
Source: S&P Global Market Intelligence. Standard template. Financial Sources.